ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
ONCT
Delisted
ONCT was delisted on the 2nd of December, 2024.
40 hedge funds and large institutions have $10.6M invested in Oncternal Therapeutics, Inc. Common Stock in 2014 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
52% less call options, than puts
Call options by funds: $27K | Put options by funds: $56K
Holders
40
Holding in Top 10
–
Calls
$27K
Puts
$56K
Top Buyers
| 1 | +$8.11M | |
| 2 | +$57.8K | |
| 3 | +$39.6K | |
| 4 |
VKH
Virtu KCG Holdings
New York
|
+$36K |
| 5 |
SIM
Spark Investment Management
New York
|
+$23K |
Top Sellers
| 1 | -$196K | |
| 2 | -$68K | |
| 3 | -$33K | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$16K |
| 5 |
RIM
Reliant Investment Management
Memphis,
Tennessee
|
-$16K |